According to official statistics from the WHO in 2022, oncological diseases are now the cause of one in every six deaths worldwide. This has encouraged the international medical community to develop new cancer treatment methods and increase the effectiveness of the already existing ones. This is particularly important for patients...
For a long time, it was believed that varicose veins could only be corrected by removing large superficial veins and ligating the perforating veins. When CHIVA was introduced in 1988, many surgeons met it with hostility. The method was not widely used because it contradicted the basic concepts of varicose vein treatment.
Ventral abdominal hernias are any defects of the abdominal wall fascia, except inguinal and hiatal hernias. Millions of surgeries for these conditions are performed worldwide each year. Most of them are carried out in an open manner, under visual control. But in developed countries, minimally invasive surgery is preferred, including laparoscopic and robot-assisted techniques.
In 2020, prostate cancer became the second most common type of cancer found in men. Cancer develops from the basal cells of the prostate gland. Over time it progresses from a small local tumor to a large formation which grows into the adjacent organs and metastasizes into the bones.
The reprogramming of differentiated cells into stem cells and some other applications, opened the door to a new age of regenerative medicine. Regulatory, medical, and aesthetic aspects are on the agenda. Both in theory and reality, a controlled cultivation of the embryonic and pluripotent stem cells from the stratified (dissected) cells has long been considered to be impossible.
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a new treatment option for peritoneal carcinomatosis. The technique was developed in 2011 by scientists from the University Hospital of Louisiana, USA. The authors suggested PIPAC as an alternative to HIPEC (hyperthermic intraperitoneal chemotherapy) in patients with peritoneal lesions against the background of diverse oncologic diseases.
Dendritic cell-based immunotherapy is the administration of individually manufactured vaccines based on the genetic characteristics of a tumor in a particular person. Cancer treatment with dendritic cells is indicated even for those patients who have not responded to all other types of therapy. In Europe, vaccination is possible in any stage of cancer and has virtually no contraindications.
Lung cancer is the most common group of malignant tumors in the world, which develops from cells in the lungs and bronchi. It develops 10% more often in men than in women. Today, Germany can offer new treatment methods, which allow for achieving excellent results even at stage 4 of the pathology. The patients' life quality can be improved, and their life expectancy can be increased as well.